Grifols SA (GRFS)
7.91
-0.16
(-1.98%)
USD |
NASDAQ |
Apr 29, 16:00
8.00
+0.09
(+1.14%)
After-Hours: 07:19
Grifols Price : 7.91 for April 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biodexa Pharmaceuticals Plc | 3.24 |
| Cellectis SA | 3.73 |
| Trinity Biotech Plc | 0.60 |
| Akari Therapeutics Plc | 5.24 |
| NuCana Plc | 2.04 |
Price Related Metrics
| PE Ratio | 11.74 |
| PS Ratio | 0.6322 |
| PEG Ratio | 0.069 |
| Price to Book Value | 2.292 |
| Price to Free Cash Flow | 7.610 |
| Earnings Yield | 8.52% |
| Market Cap | 5.383B |
| PEGY Ratio | 0.0681 |
| Operating PE Ratio | 3.801 |
| Normalized PE Ratio | 12.29 |